LRRK2 and Parkinson disease: LRRK2-PD patients showed a significantly higher basal forebrain volume compared to iPD and developed no cognitive changes over a 4-year follow-up period, potentially reflecting a compensatory cholinergic state that could prevent cognitive decline [436], which also might partially be attributed to a slower increase in NfL levels [437].